AI in Population Health: Exploring Sub-Fields and Applications

By Sumona Bose

February 1, 2024

Introduction

Artificial intelligence (AI) has influenced various aspects of healthcare, from genetics research to clinical care. However, its adoption in population health settings has been slower. In this article, we aim to shed light on different sub-fields of AI and their potential applications in population health, emphasizing the need for decision-makers to understand AI concepts. By exploring these sub-fields, we can harness the power of AI to make more informed decisions and improve public health outcomes. This article will explore the sub fields of AI in population and public health.

Understanding AI Concepts

AI methods offer the ability to analyze vast amounts of complex and diverse data, providing valuable insights and contributing to sense making. This capacity makes AI particularly appealing for health applications, including personalized medicine. However, the term “AI” encompasses various approaches and fields, leading to confusion. To bridge this knowledge gap, we will outline different AI sub-fields and their relevance to population health.

Exploring AI Sub-Fields

Machine Learning

Machine learning, a widely used sub-field of AI, has found success in clinical problem-solving. However, its application in population health and public health has been limited. Machine learning and traditional statistical approaches have the potential to leverage big data to understand and predict healthcare and population health outcomes. However, caution must be exercised to avoid biased data and unequal access to technology, which can perpetuate health inequities.

Population Health & Responsible AI
Figure 1: Population Health and Responsible AI

Natural Language Processing (NLP)

NLP focuses on understanding and processing human language. In population health, NLP can be used to analyze large volumes of text data, such as electronic health records and social media posts, to identify patterns and trends. This can aid in disease surveillance, early detection, and monitoring of public health concerns.

Computer Vision

Computer vision involves the interpretation of visual data, such as medical images and videos. In population health, computer vision can assist in the analysis of imaging data for disease diagnosis and monitoring. It can also be used for surveillance purposes, such as monitoring social distancing compliance during pandemics.

Predictive Analytics

Predictive analytics utilizes historical data to make predictions about future events. In population health, predictive analytics can help identify individuals at risk of certain diseases or adverse health outcomes. This information can guide targeted interventions and resource allocation to prevent or mitigate health issues.

Conclusion

The field of AI holds immense potential for improving population health outcomes. While AI has already made significant advancements in genetics research and clinical care, its application in population health settings has been slower. By understanding the various sub-fields of AI and their relevance to population health, decision-makers can harness the power of AI to make more informed decisions and address public health challenges. Exploring sub fields of AI in population health makes for a necessary discourse to positively intervene in population health.

Reference url

Recent Posts

Portuguese Biotech Innovation
Global Impact of Portuguese Biotech Innovation

By João L. Carapinha

June 30, 2026

Portuguese Biotech Innovation has matured into a compelling global force, with Solfarcos marking a decade of translating University of Minho research into commercial technologies that span cosmetics and pharmaceuticals. The Braga-based spin-off has built a unified platform of peptides and protein...
cannabis regulatory exploitation
Exposing Cannabis Regulatory Exploitation in Portugal’s Medicinal Sector

By João L. Carapinha

June 30, 2026

Portugal’s medicines regulator INFARMED has been shaken by a major case of cannabis regulatory exploitation in which criminal networks weaponised medicinal cannabis licences to traffic drugs on an industrial scale. Insufficient inspectors, rapid sector growth and the recruitment of former agency ...
FDA Approval Lumvoa Therapeutics
FDA Approval Lumvoa Therapeutics Redefines Treatment Landscape for Thyroid Eye Disease

By João L. Carapinha

June 29, 2026

The FDA Approval Lumvoa Therapeutics delivers the first full insulin-like growth factor-1 receptor (IGF-1R) antagonist for thyroid eye disease (TED), a rare autoimmune condition that triggers orbital inflammation, proptosis, diplopia, pain, and risk of vision loss.